BioCardia, Inc. (BCDA) stock
BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.83+0.01 (+0.61%)
Close on Nov 13, 2026Market cap $12.58MP/E –Yield –
BioCardia operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
BioCardia's operating cash flow for the twelve months ending Sep 30, 2026 was -$7.61M. For fiscal 2025 it was -$7.44M. The highest annual figure on record is $214.00K in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.44M | – |
| FY2024 | Dec 31, 2024 | -$7.89M | – |
| FY2023 | Dec 31, 2023 | -$9.97M | – |
| FY2022 | Dec 31, 2022 | -$10.56M | – |
| FY2021 | Dec 31, 2021 | -$10.37M | – |
| FY2020 | Dec 31, 2020 | -$12.36M | – |
| FY2019 | Dec 31, 2019 | -$9.45M | – |
| FY2018 | Dec 31, 2018 | -$11.07M | – |
| FY2017 | Dec 31, 2017 | -$8.67M | – |
| FY2016 | Dec 31, 2016 | -$5.52M | – |
| FY2015 | Dec 31, 2015 | -$7.02M | -3381.8% |
| FY2014 | Dec 31, 2014 | $214.00K | +692.6% |
| FY2013 | Dec 31, 2013 | $27.00K | – |
| FY2012 | Dec 31, 2012 | -$310.00K | – |
| FY2011 | Dec 31, 2011 | -$3.09M | – |
| FY2010 | Dec 31, 2010 | -$4.28M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$1.72M | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.74M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.66M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.50M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.67M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.65M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.62M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.43M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.61M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.31M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.53M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.85M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.41M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.15M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.56M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.00M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.01M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.65M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.91M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.98M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.64M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.87M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.88M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.42M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.60M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.34M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.99M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.26M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.47M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.25M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.47M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.25M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.01M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.78M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.04M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.53M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.78M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.09M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.28M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.52M | – |
See a number that looks wrong?